SOAP study
- Conditions
- D003876Atopic dermatitis
- Registration Number
- JPRN-jRCT1040230009
- Lead Sponsor
- Inuzuka Yusuke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Patients diagnosed with AD based on the UK Working Partys Diagnostic Criteria
Patients aged younger than 15 years old at recruitment
Patients whose eczema excluding the head, neck, wrists/ankles, and genitals are mild to severe
Patients who bathe or shower at least once a day
Patients whose caregivers agreed to participate in this study in writing
1. Patients with skin infection
2. Patients who apply steroid ointment, antihistamine ointment (oral is allowed), NSAIDs ointment, tacrolimus ointment, dergocitinib ointment, and difamilast ointment for diseases other than atopic dermatitis. (It is possible to apply to areas other than the intervention site.)
3. Patients taking cyclosporine, corticosteroids, baricitinib, upadacitinib, or abrocitinib
4. Patients receiving dupilumab or nemolizumab
5. Physicians decide that the patients is not appropriate for participation in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of achievement of EASI100 excluding head and neck at the end of the study
- Secondary Outcome Measures
Name Time Method EASI score excluding head and neck at the end of the study<br>POEM score at the end of the study<br>Stratum corneum hydration of the forearm at the end of the study<br>Number of occurrences of serious adverse events<br>Adverse events for which a causal relationship to the intervention cannot be denied<br>Presence or absence of contagious impetigo<br>Presence or absence of skin infections other than contagious impetigo<br>Pain during bathing (10-step scale)